Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$109.46 USD
+2.03 (1.89%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $109.54 +0.08 (0.07%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/1/24 |
---|---|
Current Quarter | 4.14 |
EPS Last Quarter | 5.02 |
Last EPS Surprise | -4.56% |
ABR | 1.56 |
Earnings ESP
|
1.91% |
---|---|
Current Year | 18.94 |
Next Year | 21.41 |
EPS (TTM) | 18.32 |
P/E (F1) | 5.67 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 938.99M | 1.01B | 4.08B | 4.41B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 977.81M | 1.03B | 4.13B | 4.64B |
Low Estimate | 903.70M | 991.00M | 4.00B | 4.15B |
Year ago Sales | 892.81M | 957.32M | 3.83B | 4.08B |
Year over Year Growth Est. | 5.17% | 5.78% | 6.34% | 8.24% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.14 | 4.67 | 18.94 | 21.41 |
# of Estimates | 12 | 10 | 12 | 12 |
Most Recent Consensus | 4.16 | 4.92 | 18.40 | 19.30 |
High Estimate | 4.38 | 4.92 | 19.75 | 25.65 |
Low Estimate | 3.73 | 4.32 | 18.40 | 17.26 |
Year ago EPS | 3.95 | 4.51 | 18.29 | 18.94 |
Year over Year Growth Est. | 4.81% | 3.55% | 3.55% | 13.08% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 0 | 1 |
Up Last 30 Days | 1 | 1 | 0 | 1 |
Up Last 60 Days | 1 | 2 | 1 | 4 |
Down Last 7 Days | 1 | 0 | 1 | 0 |
Down Last 30 Days | 2 | 1 | 1 | 0 |
Down Last 60 Days | 6 | 5 | 11 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 4.14 | 4.67 | 18.94 | 21.41 |
7 Days Ago | 4.15 | 4.67 | 18.94 | 21.41 |
30 Days Ago | 4.16 | 4.67 | 18.94 | 21.41 |
60 Days Ago | 4.23 | 4.76 | 20.26 | 22.71 |
90 Days Ago | 4.17 | 4.72 | 20.04 | 22.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 4.22 | 4.91 | 19.20 | 21.98 |
Zacks Consensus Estimate | 4.14 | 4.67 | 18.94 | 21.41 |
Earnings ESP | 1.91% | 4.94% | 1.39% | 2.64% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 5.02 | 4.84 | 4.51 | 3.95 | NA |
Estimate | 5.26 | 4.90 | 4.46 | 4.26 | NA |
Difference | -0.24 | -0.06 | 0.05 | -0.31 | -0.14 |
Surprise | -4.56% | -1.22% | 1.12% | -7.28% | -2.99% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more